Liquid purification or separation – Processes – Separating
Patent
1997-01-29
1999-06-15
Kim, John
Liquid purification or separation
Processes
Separating
2104331, 210435, 210445, 210450, 210645, 210800, 604408, 604410, B01D 3700, B01D 3900, B01D 3500, A61M 134
Patent
active
059118865
DESCRIPTION:
BRIEF SUMMARY
BACKGROUND OF THE INVENTION
The invention relates to a filter device, which is intended to separate a liquid phase from a solid phase in a biological fluid, and to its application.
This device can be used, for example, in the separation of a blood plasma cryoprecipitate. It is known that when frozen blood plasma is thawed to a temperature generally of between +1 and +4.degree. C., not only is a liquid phase obtained, but also a residue which remains solid at this temperature and which is called cryoprecipitate. The cryoprecipitate includes substances which are of therapeutic interest, such as clotting factor VIII, or the proteins which can be coagulated by thrombin, and in particular fibrinogen, fibronectin and factor XIII. Factor VIII is used in the treatment of haemophilia type A. The proteins which can be coagulated by thrombin are used, in the form of the cryoprecipitate, in particular as a "biological adhesive"; see, for example, the patent FR 2 448 900. Biological adhesives are used in surgery on account of their haemostatic and adhesive properties. Their use makes it possible to avoid forming sutures or using synthetic adhesives which are potentially toxic.
The cryoprecipitate is usually obtained from one or more samples of whole blood. Blood is taken from a healthy donor, for example, or from a patient who is registered in an autotransfusion programme, with the aid of a blood collection system comprising a number of transfer bags which are connected to each other via tubing. The blood collection bag contains an anticoagulant. The plasma is separated by centrifuging and is discharged into one of the other bags. The plasma is then frozen, and subsequently thawed to a temperature which permits fusion of the plasma, but which is sufficiently low to prevent the cryoprecipitate from solubilizing. For the preparation of a cryoprecipitate, reference may be made, for example, to the article by Masure in Vox Sang. 16, 1-9 (1969).
Special techniques can be employed to prevent contamination of the product during the preparation. The preparation is preferably done in a closed circuit, the transfers of liquids being carried out in a series of bags and tubings which have previously been connected to one another and sterilized before use.
The separation of the liquid phase and the solid phase, that is to say the separation of the residual plasma and the cryoprecipitate, can be carried out either by centrifuging or by filtration.
Centrifuging has a number of drawbacks which are inherent to this method, that is to say, in addition to the requirement to have a centrifuge available, there is the difficulty of decanting the supernatant without disturbing the centrifugation concentrate, and the difficulty of recovering the centrifugation concentrate after decantation, since this concentrate occupies a small volume, while being contained in a vessel of large volume.
Filtration also involves technical difficulties. It is necessary, in the first instance, to prevent clogging of the filter. Porous filtering membranes can be used as filters, but in practice these necessitate the use of an auxiliary pump. French Patent 2 283 700 has proposed using a thickness filter, consisting, for example, of fibrous materials forming an irregular, three-dimensional entanglement. However, with thickness filters, the difficulty lies in recovering the cryoprecipitate; in practice, it is necessary in this case to redissolve the cryoprecipitate in a suitable solvent.
SUMMARY OF THE INVENTION
With the object of remedying these various disadvantages of the prior art, the invention relates to a device with filter bag for separating a liquid phase from a solid phase in a biological fluid in which the said solid phase is in suspension, comprising: which are each made of a flexible film and are impermeable to the fluids and are sealed in a leaktight manner in a sealing zone on their periphery, in such a why as to define an internal space between the two opposite walls, holding back the said solid phase, in the form of a retentate, while permittin
REFERENCES:
patent: 2765923 (1956-10-01), Novak
patent: 3932153 (1976-01-01), Byrns
patent: 4021353 (1977-05-01), Raines et al.
patent: 4035304 (1977-07-01), Watanabe
patent: 4265762 (1981-05-01), Brenholt
patent: 4341538 (1982-07-01), Vadnay et al.
patent: 4422939 (1983-12-01), Sharp et al.
patent: 4906260 (1990-03-01), Emheiser et al.
patent: 5269924 (1993-12-01), Rochat
patent: 5543062 (1996-08-01), Nishimura
patent: 5591337 (1997-01-01), Lynn et al.
Inoteb
Kim John
LandOfFree
Device for filtration of cryoprecipitate and its application does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Device for filtration of cryoprecipitate and its application, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Device for filtration of cryoprecipitate and its application will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-400343